Header Logo

Connection

JEFFREY ROSEN to Myeloid-Derived Suppressor Cells

Back to Details
This is a "connection" page, showing publications JEFFREY ROSEN has written about Myeloid-Derived Suppressor Cells.
JEFFREY ROSEN
Connection Strength
1.186
Myeloid-Derived Suppressor Cells
  1. TIME Is a Great Healer-Targeting Myeloid Cells in the Tumor Immune Microenvironment to Improve Triple-Negative Breast Cancer Outcomes. Cells. 2020 12 23; 10(1).
    View in: PubMed
    Score: 0.707
  2. Repurposing Antiestrogens for Tumor Immunotherapy. Cancer Discov. 2017 01; 7(1):17-19.
    View in: PubMed
    Score: 0.134
  3. Fatal attraction: TICs and MDSCs. Cell Cycle. 2016 10; 15(19):2545-2546.
    View in: PubMed
    Score: 0.131
  4. Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation. Nat Cell Biol. 2016 06; 18(6):632-44.
    View in: PubMed
    Score: 0.128
  5. CD8+ T cells inhibit metastasis and CXCL4 regulates its function. Br J Cancer. 2021 07; 125(2):176-189.
    View in: PubMed
    Score: 0.045
  6. Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms. Nat Cell Biol. 2019 09; 21(9):1113-1126.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.